Casdin Capital's book
34 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Resilience (Blue Ash) | — | $9.4B | — | — | |
| Aledade | Enterprise Systems (Healthcare) | $3.5B | — | — | |
| Komodo Health | — | $3.3B | — | — | |
| Formation Bio | Drug Discovery | $1.7B | — | — | |
| Thyme Care | — | $1.5B | — | — | |
| Treeline Biosciences | — | $1.3B | — | — | |
| Parabilis Medicines | Drug Discovery | $920.0M | — | — | |
| DNA Script | Biotechnology | $659.7M | — | — | |
| Verana Health | — | $628.7M | — | — | |
| Umoja Biopharma | — | $420.0M | — | — | |
| + 24 more companies · a free account shows the top 25 | |||||
Free account
See the whole book
- ·The book's top 25 — of 34 recorded positions
- ·Watchlist + alerts for Casdin Capital's activity
Create free account
No card required